News | SCCT | July 08, 2019

Jonathon Leipsic Awarded 2019 DeHaan Award for Innovation in Cardiology

Leipsic to use $200,000 grant from annual SCCT award to further research on mechanisms of bioprosthetic valve failure

Jonathon Leipsic Awarded 2019 DeHaan Award for Innovation in Cardiology

July 8, 2019 – Jonathon A. Leipsic, M.D., FSCCT, is the recipient of the 2019 DeHaan Award for Innovation in Cardiology, announced by the Society of Cardiovascular Computed Tomography (SCCT). Leipsic will present the second Dehaan Award Lecture at the SCCT 14th Annual Scientific Meeting, July 11-14 in Baltimore. The award, presented by the Jon DeHaan Foundation, includes a $200,000 grant.

Leipsic is the chairman of the department of radiology for Providence Health Care and the vice-chairman of research and a professor of radiology and cardiology for the University of British Columbia. He is a past president of the SCCT (2015-2016) and will also be awarded the SCCT Gold Medal Award in 2019.

Read the article "SCCT Announces 2019 Gold Medal Award Recipients"

“Dr. Leipsic has been a tireless champion, teacher and leader in cardiac applications of CT for many years. He has devoted countless hours toward advancing the field, and at the same time has thus touched many patients multiplied by the number of cardiologists who have used his work or who have learned from him directly.” said Robert Schwartz, M.D., chairman of the board for the Jon DeHaan Foundation. “It is a great pleasure that Dr. Leipsic has been chosen for the Jon H. DeHaan Foundation award for cardiovascular excellence in imaging, the purpose of which is to further his work and teaching, thus advancing cardiac CT far into the future.”

Leipsic intends to build on past work delving into the mechanisms of bioprosthetic valve failure. The data suggests that the mechanisms and timelines of valve degeneration are consistent across surgical and transcatheter bioprosthetic heart valves, and a better understanding of structural valve degeneration can be obtained through combining further histological and novel imaging approaches. Leipsic will continue along this path of investigation through the generous support of the DeHaan Foundation Award, which will allow him to perform the needed advanced analyses to help advance understanding of this complex process and potentially develop solutions to this important clinical problem.

The award lecture at the SCCT Annual Scientific Meeting, generously supported by the Jon Holden DeHaan Foundation, helps promote the knowledge and the use of cardiovascular CT to improve patient outcomes.

For more information: www.scct.org

Related Content

VIDEO: The Essentials of CT Transcatheter Valve Imaging

VIDEO: What to Look for in CT Structural Heart Planning Software

Related Content

New Multimodality Cardiac Imaging Guidelines for Competitive Athletes Created. ASE SCCT and SCMR recommendations for imaging, screening atheletes.
News | Cardiac Imaging | May 11, 2020
May 11, 2020 – Competitive athletes are a rapidly growing population worldwide.
Figure 4 for the study. Images of a 65-year-old man (patient 6). (a) Cardiac MRI perfusion shows perfusion deficit of anterior/anterolateral wall attributed to left anterior descending artery/left circumflex artery (*). (b) CT coronary angiography. (c) Coronary angiography, left anterior oblique projection with caudal angulation. (d) Three-dimensional image fusion helped refine diagnosis: perfusion deficits (*) were most likely caused by narrow first diagonal branch and its first, stented side branch (arrow

Figure 4 for the study. Images of a 65-year-old man (patient 6). (a) Cardiac MRI perfusion shows perfusion deficit of anterior/anterolateral wall attributed to left anterior descending artery/left circumflex artery (*). (b) CT coronary angiography. (c) Coronary angiography, left anterior oblique projection with caudal angulation. (d) Three-dimensional image fusion helped refine diagnosis: perfusion deficits (*) were most likely caused by narrow first diagonal branch and its first, stented side branch (arrowhead). Retrospectively, denoted lesion could also be found at CT coronary angiography and coronary angiography (arrowheads in b and c, respectively). CT FFR = CT-derived fractional flow reserve, LGE = late gadolinium enhancement. Image courtesy of RSNA, Radiology.

News | Cardiac Imaging | May 04, 2020
May 4, 2020 – A new technique that combines computed tomography (CT) and magnetic resonance imaging MRI can bolster c
An example of a coronary computed tomography angiography (CCTA) exam. The CIAO study looked at patients who have a problem of blood flow limitation and chest pain symptoms in the absence of a 50 percent or more artery narrowing, known as ischemia with no obstructive CAD, or INOCA.

An example of a coronary computed tomography angiography (CCTA) exam. The CIAO study looked at patients who have a problem of blood flow limitation and chest pain symptoms in the absence of a 50 percent or more artery narrowing, known as ischemia with no obstructive CAD, or INOCA.

News | Cardiac Imaging | April 03, 2020
April 3, 2020 — Patients who experience chest pain and have abnormal results on a cardiac stress test but who do not
Schematic depiction of the automated process for assessing fat, muscle, liver, aortic calcification, and bone from original abdominal CT scan data

Figure 1: Depiction of the fully automated CT biomarkers tools used in this study. (A) Schematic depiction of the automated process for assessing fat, muscle, liver, aortic calcification, and bone from original abdominal CT scan data. (B) Case example in an asymptomatic 52-year-old man undergoing CT for colorectal cancer screening. At the time of CT screening, he had a body-mass index of 27·3 and Framingham risk score of 5% (low risk). However, several CT-based metabolic markers were indicative of underlying disease. Multivariate Cox model prediction based on these three CT-based results put the risk of cardiovascular event at 19% within 2 years, at 40% within 5 years, and at 67% within 10 years, and the risk of death at 4% within 2 years, 11% within 5 years, and 27% within 10 years. At longitudinal clinical follow-up, the patient suffered an acute myocardial infarction 3 years after this initial CT and died 12 years after CT at the age of 64 years. (C) Contrast-enhanced CT performed 7 months before death for minor trauma was interpreted as negative but does show significant progression of vascular calcification, visceral fat, and hepatic steatosis. HU=Hounsfield units.

News | Cardiac Imaging | March 06, 2020
March 6, 2020 — Researchers at the National Institutes of Health a
ASNC Announces Multisocietal Cardiac Amyloidosis Imaging Consensus
News | Cardiac Imaging | September 09, 2019
The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along with eight other...
Philips Debuts Cardiac Ultrasound and Enterprise Informatics Offerings at ESC 2019
News | Cardiac Imaging | August 30, 2019
Philips will showcase its latest cardiac care innovations at the European Society of Cardiology (ESC) Congress 2019,...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Cardiac Imaging | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...